All Articles
FirmPortfolio
In November 2023, we hosted an exclusive gathering of leading investors, entrepreneurs, and industry luminaries at Menlo Ventures’ Annual Meeting + CEO Summit.
PortfolioFunding
Menlo’s Investment in OfferFit: Building the ML-Powered, Automated Experimentation Platform Marketers Need
We’re thrilled to lead OfferFit’s Series B and believe it delivers a category-disrupting solution at a time when the marketing world is looking to…
PerspectivePortfolio
2023: The State of Generative AI in the Enterprise
Menlo Ventures surveyed more than 450 enterprise executives to provide a view into generative AI adoption in the enterprise today.
PortfolioFunding
Empowering Behavioral Health Providers With AI: Our Investment in Eleos
Eleos is the leader in CareOps Automation for behavioral health and joins Menlo Ventures’ exciting portfolio of healthcare software and AI companies.
PortfolioFunding
Hardening the Data Moat: Our Investment in Cleanlab
With Cleanlab, AI teams automate weeks of manual data labeling and bypass dozens of engineering hours for model training and deployment.
Firm
Menlo Welcomes Former Atlassian CPO Joff Redfern to Our Investment Team
Joff joins our team of deep and complementary operators and, in particular, adds world-class expertise in finding product-market fit and scaling product organizations.
Perspective
Opportunities and Challenges of Applying Generative AI to Designing New Drugs
Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world…
PerspectivePortfolio
Generative AI: Lessons From Prior Waves
While navigating this exciting yet complex landscape may seem daunting for startups, lessons from past tech waves, along with a thoughtful, strategic approach, can…
PortfolioFunding
Our Investment in Anthropic: The Foundation Layer for Generative AI
We stand on the precipice of an extraordinary platform shift catalyzed by groundbreaking advancements in generative artificial intelligence.
PortfolioPerspective
Video: Engineering New Drugs With Generative AI at Genesis Therapeutics
Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.
FundingPortfolio
Our Investment in Luca: The AI-Driven Pricing Co-Pilot for Large E-commerce Companies
Retail e-commerce is as old as the advent of the web. In the decades that followed, a wave of innovation across supply chain, logistics,…
PerspectivePortfolio
The Seven Generative AI Building Blocks for the Next Generation of Consumer Technology Companies
OpenAI’s ChatGPT reached 100 million monthly active users just two months after launch, setting the new standard for the fastest-growing consumer application in history.…